| [1] |
1 Ryo A, Liou YC, Lu KP, et al. Prolyl isomerase Pinl: a catalyst for oncogenesis and a potential therapeutic target in cancer [J], J Cell Sci, 2003, ll6(5):773～783
2 Ayala G, Wang D, Wulf G, et al. The Prolyl isomerase Pinl is a novel prognostic marker in human prostate cancer[J]. Cancer Res. 2003, 63(Oct.l):6244～625l
3 Ranganathan R, Lu KP, Hunter T, et al. Structural and functional analysis of the mitotic peptidyl prolyl isomerase Pinl suggests that substrate recognition is phosphorylation dependent [J], Cell, l997. 89(Junel3): 875～886
4 Lu KP, Liou YC, Zhou XZ. Pinning down proline —directed Phosphorylation signaling[J]. Trends Cell Biol, 2002, l2(4):l64～l72
5 Lu KP. Pinning down cell signaling, cancer and Alzheimer's dis-ease[J]. Trends Biochem Sci, 2004, 29(4): 200-209 6 Bao L, Kimzey A, Sauter G, et al. Prevalent overexpression of prolyl isomerase Pinl in human cancers [J]. Am J Pathol, 2004,l64(5):l727～l737
7 Wulf GM, Ryo A, Wulf GG, et al. Pinl is overexpressed in breast cancer and potentiates the transcriptional activity of phos-phorylated c—Jun towards the cyclin Dl gene [J]. EMBO J, 200l, 20(l3):3459～3472
8 Duchrow M, Gerdes J, Schluter C, et al. The proliferation—associated Ki—67 protein: definition in molecular terms [J]. Cell Prolif, l994, 27(5):235～242
9 Kruse AJ, Baak JP, Janssen EA, et al. Ki67 predicts progression in early CIN: validation of a multivariate progression—risk model[J]. Cell Oncol, 2004, 26(l—2):l3～20
10 Padovan P, Salmaso R, Marchetti M, et al. Prognostic value of bcl—2, p53 and Ki—67 in invasive squamous carcinoma of uterine cervix[J]. EurJ Gynaecol Oncol, 2000, 2l(3):267～272
11 Li H, Byeon IJ, Ju Y, et al. Structure of human Ki67 FHA domain and its binding to a phosphoprotein fragment from hNlFK reveal unique recognition sites and new views to the structural basis of FHA domain functions[J].J Mol Biol, 2004, 335(l):37l～38l
|
下载:
